Literature DB >> 25560279

Malignancies in pemphigus and pemphigoid diseases.

Franziska Schulze1, Kathrin Neumann2, Andreas Recke1, Detlef Zillikens1, Roland Linder3, Enno Schmidt4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25560279     DOI： 10.1038/jid.2014.547

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  13 in total

Review 1.  Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome.

Authors:  John R Stanley; Masayuki Amagai
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

2.  Anti-epiligrin cicatricial pemphigoid and relative risk for cancer.

Authors:  C A Egan; Z Lazarova; T N Darling; C Yee; T Coté; K B Yancey
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

Review 3.  Pemphigoid and cancer.

Authors:  B Lindelöf; N Islam; G Eklund; L Arfors
Journal:  Arch Dermatol       Date:  1990-01

4.  Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.

Authors:  G J Anhalt; S C Kim; J R Stanley; N J Korman; D A Jabs; M Kory; H Izumi; H Ratrie; D Mutasim; L Ariss-Abdo
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

Review 5.  Pemphigoid diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Lancet       Date:  2012-12-11       Impact factor: 79.321

Review 6.  Conjunctival mucoepidermoid carcinoma in a patient with ocular cicatricial pemphigoid and a review of the literature.

Authors:  Jennifer W Robinson; Seymour Brownstein; David R Jordan; William G Hodge
Journal:  Surv Ophthalmol       Date:  2006 Sep-Oct       Impact factor: 6.048

7.  Incidence and mortality of bullous pemphigoid in France.

Authors:  Pascal Joly; Sophie Baricault; Agnès Sparsa; Philippe Bernard; Christophe Bédane; Sophie Duvert-Lehembre; Philippe Courville; Pierre Bravard; Brigitte Rémond; Valérie Doffoel-Hantz; Jacques Bénichou
Journal:  J Invest Dermatol       Date:  2012-03-15       Impact factor: 8.551

8.  Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid.

Authors:  Philippe Bernard; Frank Antonicelli; Christophe Bedane; Pascal Joly; Christelle Le Roux-Villet; Sophie Duvert-Lehembre; Patricia Rousselle; Catherine Prost-Squarcioni
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

9.  Associations between bullous pemphigoid and primary malignant cancers: an English national record linkage study, 1999-2011.

Authors:  Eugene Ong; Raph Goldacre; Uy Hoang; Rodney Sinclair; Michael Goldacre
Journal:  Arch Dermatol Res       Date:  2013-08-04       Impact factor: 3.017

10.  Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.

Authors:  S M Langan; L Smeeth; R Hubbard; K M Fleming; C J P Smith; J West
Journal:  BMJ       Date:  2008-07-09
View more
  17 in total

Review 1.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 2.  Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 3.  Bullous pemphigoid: An immune disorder related to aging (Review).

Authors:  Maria Ludovica Deotto; Alice Spiller; Alvise Sernicola; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2021-11-15       Impact factor: 2.447

4.  Coincidence of Bullous Pemphigoid and Pityriasis Rubra Pilaris.

Authors:  Irina Gasslitter; Judith Löffler-Ragg; Enno Schmidt; Matthias Schmuth; Robert Gruber
Journal:  Acta Derm Venereol       Date:  2022-03-22       Impact factor: 3.875

5.  Coexistent Solid Malignancies in Pemphigus: A Population-Based Study.

Authors:  Khalaf Kridin; Shira Zelber-Sagi; Doron Comaneshter; Arnon D Cohen
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

6.  Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.

Authors:  Hywel C Williams; Fenella Wojnarowska; Gudula Kirtschig; James Mason; Thomas R Godec; Enno Schmidt; Joanne R Chalmers; Margaret Childs; Shernaz Walton; Karen Harman; Anna Chapman; Diane Whitham; Andrew J Nunn
Journal:  Lancet       Date:  2017-03-06       Impact factor: 79.321

Review 7.  Bullous pemphigoid.

Authors:  Denise Miyamoto; Claudia Giuli Santi; Valéria Aoki; Celina Wakisaka Maruta
Journal:  An Bras Dermatol       Date:  2019-05-09       Impact factor: 1.896

Review 8.  Bullous Autoimmune Dermatoses–Clinical Features, Diagnostic Evaluation, and Treatment Options.

Authors:  Nina van Beek; Detlef Zillikens; Enno Schmidt
Journal:  Dtsch Arztebl Int       Date:  2021-06-18       Impact factor: 8.251

9.  Increased Risk of Squamous Cell Carcinoma of the Skin and Lymphoma Among 5,739 Patients with Bullous Pemphigoid: A Swedish Nationwide Cohort Study.

Authors:  Zeyad Albadri; Kristofer Thorslund; Henrike Häbel; Oliver Seifert; Carina Grönhagen
Journal:  Acta Derm Venereol       Date:  2020-10-14       Impact factor: 3.875

10.  Pemphigus vulgaris as the first manifestation of multiple myeloma: a case report.

Authors:  Fandresena Arilala Sendrasoa; Irina Mamisoa Ranaivo; Mendrika Fifaliana Rakotoarisaona; Onivola Raharolahy; Naina Harinjara Razanakoto; Malalaniaina Andrianarison; Lala Soavina Ramarozatovo; Fahafahantsoa Rapelanoro Rabenja
Journal:  J Med Case Rep       Date:  2018-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.